---

---

published : This month    entities : Johnson & johnson    symbols : Jnj   

save search

---

Why Biopharma Companies Avoid Hiring People Who Need Visas
Published: 2024-04-25 (Crawled : 05:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| Email alert Add to watchlist
companies avoid biopharma

---

Stargardt Disease Market to Grow Rapidly at a CAGR of 32% by 2034 | DelveInsight
Published: 2024-04-24 (Crawled : 22:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| Email alert Add to watchlist
OTLK | News P | $8.2 0.0% 240K |

Health Technology

| Email alert Add to watchlist
KOD | News | $3.37 1.2% 1.19% 340K |

Health Technology

| Email alert Add to watchlist
OPT | News | $3.46 2.98% 2.89% 8.2K |

Health Technology

| Email alert Add to watchlist
disease market

---

NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results
Published: 2024-04-24 (Crawled : 21:00) - globenewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| Email alert Add to watchlist
NBTX | $5.71 1.04% 1.4K |

Manufacturing

| Email alert Add to watchlist
business year update financial results

---

Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
CDTX | News | $11.94 16.49% 14.15% 170K |

Health Technology

| Email alert Add to watchlist
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| Email alert Add to watchlist
cd388 million global commercial therapeutics development

---

First Approval for Rare Pediatric Cancer; New OTC Opioid Overdose Option
Published: 2024-04-24 (Crawled : 16:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| -0.27% | O: 0.8% H: 0.0% C: -1.05%
PRGO | $31.23 2.43% 0.0% 960K |

Health Technology

| 2.43% | O: -0.03% H: 2.66% C: 2.46%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -1.02% | O: -1.02% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -0.65% | O: -0.82% H: 0.37% C: 0.17%
XOMA | $25.11 -3.76% -3.9% 8.2K |

Health Technology

| -1.72% | O: 0.19% H: 0.0% C: -1.91%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 0.82% | O: 0.82% H: 0.0% C: 0.0%
rare first opioid approval for

---

CureVac Appoints Thaminda Ramanayake as New Chief Business Officer
Published: 2024-04-24 (Crawled : 15:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| -0.27% | O: 0.8% H: 0.0% C: -1.05%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -1.02% | O: -1.02% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 0.82% | O: 0.82% H: 0.0% C: 0.0%
CVAC | $2.51 -3.46% -3.59% 1.1M |

Health Technology

| -3.46% | O: -4.62% H: 4.44% C: 1.21%
business

---

BigHat Biosciences Enters Into Strategic Collaboration to Leverage Machine Learning in Antibody Discovery & Design
Published: 2024-04-24 (Crawled : 13:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -1.02% | O: -1.02% H: 0.0% C: 0.0%
antibody collaboration design

---

Biopharma Layoff Tracker 2024: Tessera, BMS, Pfizer and More Cut Staff
Published: 2024-04-24 (Crawled : 12:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| -0.27% | O: 0.8% H: 0.0% C: -1.05%
RLYB | News | $1.59 -8.62% -9.43% 280K |

| -12.47% | O: -3.05% H: 0.0% C: -9.71%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -1.02% | O: -1.02% H: 0.0% C: 0.0%
VXRT | News | $0.7051 -5.41% -5.72% 1.5M |

Health Technology

| -8.39% | O: -1.94% H: 0.0% C: -6.58%
TXMD | News | $1.88 -0.27% 15K |

Health Technology

| 2.13% | O: 0.53% H: 2.12% C: 1.59%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 0.82% | O: 0.82% H: 0.0% C: 0.0%
PTCT | News S | $25.19 -0.87% -0.87% 560K |

Health Technology

| -2.95% | O: -0.71% H: 0.81% C: -2.25%
NKTR | News | $1.39 -2.11% -2.16% 960K |

Health Technology

| -0.36% | O: -1.08% H: 3.65% C: 0.73%
MOR | News | $18.07 0.17% 0.17% 130K |

Health Technology

| 0.06% | O: 0.0% H: 0.28% C: 0.06%
GLPG | News | $28.78 -2.28% -2.33% 140K |

Health Technology

| -1.41% | O: 0.48% H: 0.17% C: -1.88%
AMRN | News | $0.8844 0.13% 0.12% 660K |

Health Technology

| 0.57% | O: 0.57% H: 1.14% C: 0.0%
GOOGL | News 4 | $159.18 0.58% 0.58% 22M |

Technology Services

| 1.34% | O: 0.29% H: 1.31% C: 1.04%
GOOG | News 4 | $161.05 0.71% 0.7% 19M |

Technology Services

| 1.58% | O: 0.32% H: 1.45% C: 1.26%
OCX | News | $2.3 -6.31% -6.74% 41K |

Health Technology

| 0.0% | O: 2.03% H: 0.0% C: -1.99%
biopharma

---

Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimilar for Simponi® (golimumab)
Published: 2024-04-24 (Crawled : 08:00) - globenewswire.com
ALVO | $13.5 0.75% 0.74% 190K |

n/a

| 1.04% | O: 1.12% H: 1.48% C: -0.07%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -1.02% | O: -1.02% H: 0.0% C: 0.0%
avt05 simponi biosimilar for topline results study

---

Xaira Therapeutics Launches to Deliver Transformative Medicines by Advancing and Harnessing AI for Drug Discovery and Development
Published: 2024-04-24 (Crawled : 08:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -1.02% | O: -1.02% H: 0.0% C: 0.0%
drug for therapeutics development

---

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors
Published: 2024-04-24 (Crawled : 07:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -1.02% | O: -1.02% H: 0.0% C: 0.0%
precision company million series therapeutics

---

Biopharma Layoff Tracker 2024: Tessera, BenevolentAI, Pfizer and More Cut Staff
Published: 2024-04-24 (Crawled : 05:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| -0.27% | O: 0.8% H: 0.0% C: -1.05%
RLYB | News | $1.59 -8.62% -9.43% 280K |

| -12.47% | O: -3.05% H: 0.0% C: -9.71%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -1.02% | O: -1.02% H: 0.0% C: 0.0%
VXRT | News | $0.7051 -5.41% -5.72% 1.5M |

Health Technology

| -8.39% | O: -1.94% H: 0.0% C: -6.58%
TXMD | News | $1.88 -0.27% 15K |

Health Technology

| 2.13% | O: 0.53% H: 2.12% C: 1.59%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 0.82% | O: 0.82% H: 0.0% C: 0.0%
PTCT | News S | $25.19 -0.87% -0.87% 560K |

Health Technology

| -2.95% | O: -0.71% H: 0.81% C: -2.25%
NKTR | News | $1.39 -2.11% -2.16% 960K |

Health Technology

| -0.36% | O: -1.08% H: 3.65% C: 0.73%
MOR | News | $18.07 0.17% 0.17% 130K |

Health Technology

| 0.06% | O: 0.0% H: 0.28% C: 0.06%
GLPG | News | $28.78 -2.28% -2.33% 140K |

Health Technology

| -1.41% | O: 0.48% H: 0.17% C: -1.88%
AMRN | News | $0.8844 0.13% 0.12% 660K |

Health Technology

| 0.57% | O: 0.57% H: 1.14% C: 0.0%
GOOGL | News 4 | $159.18 0.58% 0.58% 22M |

Technology Services

| 1.34% | O: 0.29% H: 1.31% C: 1.04%
GOOG | News 4 | $161.05 0.71% 0.7% 19M |

Technology Services

| 1.58% | O: 0.32% H: 1.45% C: 1.26%
OCX | News | $2.3 -6.31% -6.74% 41K |

Health Technology

| 0.0% | O: 2.03% H: 0.0% C: -1.99%
biopharma

---

Tactile Medical Announces CEO Transition and Preliminary First Quarter 2024 Revenue
Published: 2024-04-23 (Crawled : 20:00) - globenewswire.com
MDT | $80.38 -1.12% 0.0% 5M |

Health Technology

| -1.12% | O: -0.64% H: 0.07% C: -0.48%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -1.02% | O: -1.02% H: 0.0% C: 0.0%
TCMD | $15.04 3.23% 3.12% 410K |

Health Technology

| 3.23% | O: -0.14% H: 7.15% C: 3.37%
first ceo revenue medical

---

Incyte Breaks Mid-April M&A Lull With Escient Purchase
Published: 2024-04-23 (Crawled : 14:30) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -0.13% | O: 0.89% H: 0.0% C: 0.0%

---

Biopharma Layoff Tracker 2024: BenevolentAI, Pfizer, Sanofi and More Cut Staff
Published: 2024-04-23 (Crawled : 14:30) - biospace.com/
RLYB | News | $1.59 -8.62% -9.43% 280K |

| -10.73% | O: 1.98% H: 0.0% C: 0.0%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -0.13% | O: 0.89% H: 0.0% C: 0.0%
VXRT | News | $0.7051 -5.41% -5.72% 1.5M |

Health Technology

| -6.58% | O: 1.97% H: 0.0% C: 0.0%
TXMD | News | $1.88 -0.27% 15K |

Health Technology

| 2.13% | O: -0.53% H: 1.07% C: 0.53%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 2.53% | O: 1.7% H: 0.0% C: 0.0%
PTCT | News S | $25.19 -0.87% -0.87% 560K |

Health Technology

| -2.93% | O: 0.02% H: 0.0% C: 0.0%
NKTR | News | $1.39 -2.11% -2.16% 960K |

Health Technology

| 1.47% | O: 1.84% H: 0.0% C: 0.0%
MOR | News | $18.07 0.17% 0.17% 130K |

Health Technology

| 0.45% | O: 0.39% H: 0.0% C: 0.0%
GLPG | News | $28.78 -2.28% -2.33% 140K |

Health Technology

| -1.03% | O: 0.38% H: 0.0% C: 0.0%
AMRN | News | $0.8844 0.13% 0.12% 660K |

Health Technology

| 1.15% | O: 0.57% H: 0.0% C: 0.0%
GOOGL | News 4 | $159.18 0.58% 0.58% 22M |

Technology Services

| 1.82% | O: 0.48% H: 0.0% C: 0.0%
GOOG | News 4 | $161.05 0.71% 0.7% 19M |

Technology Services

| 1.99% | O: 0.41% H: 0.0% C: 0.0%
OCX | News | $2.3 -6.31% -6.74% 41K |

Health Technology

| -1.99% | O: -1.99% H: 0.0% C: 0.0%
biopharma sanofi

---

FDA Rejects Abeona’s Gene Therapy, Approves ImmunityBio’s Bladder Cancer Treatment
Published: 2024-04-23 (Crawled : 13:30) - biospace.com/
PRGO | $31.23 2.43% 0.0% 960K |

Health Technology

| 3.89% | O: 0.13% H: 1.89% C: 1.3%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -0.13% | O: 0.89% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -0.17% | O: 0.56% H: 0.41% C: -0.07%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 2.53% | O: 1.7% H: 0.0% C: 0.0%
fda bladder cancer treatment

---

Top Biopharma Brands Reach Audiences 10x More Qualified with Veeva Crossix Prime Segments
Published: 2024-04-23 (Crawled : 11:00) - prnewswire.com
VEEV | $200.52 -0.29% -0.26% 540K |

Technology Services

| 0.85% | O: 1.02% H: 2.26% C: 0.12%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -0.13% | O: 0.89% H: 0.0% C: 0.0%
brands reach biopharma prime

---

Dry Age-related Macular Degeneration Seven Major Market to Exhibit Growth at a CAGR of 19.8% by 2034 | DelveInsight
Published: 2024-04-22 (Crawled : 22:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -0.13% | O: 0.89% H: 0.0% C: 0.0%
OTLK | News P | $8.2 0.0% 240K |

Health Technology

| 1.36% | O: 1.48% H: 2.8% C: -0.12%
OPT | News | $3.46 2.98% 2.89% 8.2K |

Health Technology

| 1.48% | O: 3.25% H: 0.0% C: -3.72%
OCUL | News | $4.645 -7.1% -7.64% 3.9M |

Health Technology

| -8.66% | O: 0.79% H: 0.59% C: -2.34%
KOD | News | $3.37 1.2% 1.19% 340K |

Health Technology

| -1.17% | O: 0.29% H: 3.79% C: -2.92%
EYPT | News | $16.47 -6.26% -6.68% 1.1M |

Health Technology

| -2.83% | O: 7.73% H: 2.3% C: -3.78%
CLSD | News P | $1.33 -2.92% -3.01% 200K |

Health Technology

| -4.96% | O: 1.42% H: 3.5% C: -4.2%
ADVM | News | $10.19 -7.36% -7.95% 310K |

Health Technology

| -10.14% | O: -0.26% H: 4.95% C: -2.74%
macular growth market

---

ArriVent Appoints Kristine Peterson to its Board of Directors
Published: 2024-04-22 (Crawled : 20:00) - globenewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -0.13% | O: 0.89% H: 0.0% C: 0.0%

---

CARVYKTI® (ciltacabtagene autoleucel) Approved by the European Commission for Second-line Treatment of Patients with Relapsed and Refractory Multiple Myeloma
Published: 2024-04-22 (Crawled : 18:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| 0.16% | O: 0.29% H: 0.0% C: 0.0%
LEGN | News | $45.205 -4.73% -4.97% 1.1M |

Health Technology

| -2.21% | O: 0.39% H: 1.73% C: 1.49%
carvykti approved treatment for

---

Gainers vs Losers

62%

38%

Top 10 Gainers

CSSE 4 | $0.4323 183.85% 64.77% 220M |

Consumer Services

BOF | $1.99 70.09% 41.21% 110M |

ILAG | $0.51 6.03% 40.62% 1.7M |

LICN | $0.941 68.04% 40.49% 15M |

AMST | $3.31 65.5% 39.58% 70M |

Technology Services

MTC | $3.615 61.38% 38.04% 9.3M |

Technology Services

WIMI | $1.15 58.53% 36.92% 19M |

Technology Services

AIH | $0.45 12.5% 30.92% 320K |

Health Services

MULN | News | $3.78 38.46% 27.78% 13M |

Information

RILY | $29.86 37.48% 27.26% 12M |

Finance

---

Your saved searches

---